Are you having trouble remembering when you started taking digestive enzymes to control your indigestion? When was the last time you took an anti-inflammatory enzyme for joint pain, and what exactly was the name of that product?

If you’re having trouble remembering your health history, or you just want to keep tabs on the lifestyle and supplement choices you’ve been making to stay healthy, Internet giant Google might have the service you’re looking for.

In late February, the Enzyme Experts news site reported on Google’s medical records service – then in test marketing – which was created to provide password-protected online access to personal health profiles. A year and a half into its creation, Google released the much-anticipated program, Google Health, in mid-May.

At www.google.com/health, consumers have the opportunity to record their use of health care services, products and related spending, according to a New York Times story. This personal information can then be sent to health practices, or, practices can send information to individualized Google files.

The landing page of Google Health also includes a link that allows users to search for health information. One advantage of Google Health, the story says, is that it provides health care practitioners with a clearer picture of what types of drugs or supplements a patient is taking.

May 19, 2008

Dear Health Care Practitioner,

It was recently brought to our attention by one of our customers that Dr. Ellen Cutler, owner of BioSET, Inc., has taken steps in the past few months to discontinue the relationship between BioSET, Inc. and Empire Health, LLC/Enzymes, Inc. Unfortunately, Dr. Cutler chose not to discuss her intentions with Empire Health, LLC/Enzymes, Inc. directly, therefore preventing the two sides from negotiating an amicable separation. Instead, Dr. Cutler has secretly attempted to duplicate formulations in the BioSET product line in order to circumvent Empire Health, LLC/Enzymes, Inc. Moreover, Dr. Cutler has placed BioSET customers in an awkward position by contacting them regarding her plans.

Empire Health, LLC/Enzymes, Inc. has no choice but to end its relationship with Dr. Ellen Cutler and the BioSET organization effective immediately.

The BioSET, Inc./Enzymes, Inc. relationship began nine years ago when Dr. Cutler approached Enzymes, Inc. in search of a product line that was more compatible with the BioSET System than the one she was endorsing at the time. The technical staff of Enzymes, Inc., consisting of biochemists and a medical doctor with more than 30 years of combined experience formulating enzyme-based products for health care practitioners, accepted the challenge of developing a line of high-quality, innovative products to meet the needs of Dr. Cutler and BioSET. Dr. Cutler was so pleased with the therapeutic effectiveness of these products that she permitted Enzymes, Inc. to promote them to health care practitioners using the BioSET trademark and her endorsement for the past nine years.

During those years, Enzymes, Inc. has remained loyal to and supportive of Dr. Cutler through her many professional and personal trials and tribulations. For the sake of its customers, Enzymes, Inc. has made every effort to help bring stability to the ever-changing BioSET organization. Two years ago, when the BioSET organization was floundering, Dr. Cutler formed a partnership with natural health care industry veteran Frank Guzzo to manage all activities for BioSET, Inc. Encouraged by this positive move, Enzymes, Inc. agreed to work with Frank Guzzo to create a new entity, Empire Health, LLC, which would facilitate the marketing and distribution of the BioSET product line, as well as coordinate BioSET seminars.

The goal of Empire Health, LLC/Enzymes, Inc. has always been to provide the best possible products to health care practitioners combined with exceptional technical support and reasonable pricing. It has become clear during the past year that Dr. Cutler’s business methods and motivations differ dramatically from those of Empire Health, LLC/Enzymes, Inc. The inability of Empire Health, LLC to reach a contractual agreement with Dr. Cutler despite its good faith efforts, coupled with Dr. Cutler’s arbitrary termination of Frank Guzzo’s partnership in BioSET, Inc., has led to the realization that any type of continued relationship with Dr. Ellen Cutler and BioSET, Inc. is impossible.

Empire Health, LLC/Enzymes, Inc. apologizes for any inconvenience this separation from BioSET, Inc. may cause you or your practice. We have immediately begun phasing out product bottles bearing the BioSET logo but will continue to sell the same formulations with the same clinically-proven proprietary ingredients such as PhysioProtease™ and Protease GL.™ To avoid patient confusion, the label design will remain the same with only the BioSET logo being replaced. In addition, the separation from BioSET allows us to offer more favorable pricing on all products, as well as add new, innovative products to the line. Private label opportunities are also now possible.

Of course, you will continue to receive the same excellent customer service and technical support you have come to expect from Empire Health, LLC/Enzymes, Inc. To benefit your practice further, we will be sponsoring educational opportunities on a wide range of topics, including enzyme therapy and bioenergetic medicine, in convenient formats at reasonable prices.

Thank you for your patience during this transition. We look forward to continuing to help you build your practice. Please don’t hesitate to contact either one of us if you have questions or concerns regarding this matter.

Yours for Better Health,

Frank Guzzo
President
Empire Health, LLC
8500 NW River Park Drive, #227
Parkville, MO 64152
(877) 617-7717
(415) 717-7702
frank@empirehealthllc.com

Lynn S. Greaves
Vice President
Empire Health, LLC/Enzymes, Inc.
8500 NW River Park Drive, #227
Parkville, MO 64152
800-637-7893
(816) 746-6461 ext. 308
lgreaves@enzymesinc.com

Although only a matter of one percentage point, the number of insured Americans taking prescription drugs for chronic conditions has now surpassed half, according to a mid-May Associated Press story.

From 2003 to 2006, 50% of Americans fell into that category. Now, 51% regularly take one or more prescriptions, the AP says.

The most commonly used drugs were those for lowering high blood pressure and cholesterol. Experts in the story attributed some of the increased prescription use to health problems stemming from obesity, as well as to the continual advertising of prescription drugs.

An early April story at Enzyme Experts explains that Vytorin, for the treatment of high cholesterol, failed to reduce heart disease risk in a clinical trial, according to a March 31 CBS/Associated Press story.

Another story from CNN said the use of Vytorin and Zetia, a component of Vytorin, significantly increased in the U.S. when they were featured in a $200 million advertising campaign. Sales were four times lower in Canada, where drug ads aren’t allowed.

Several other pharmaceutical drugs, as explained at Enzyme Experts, have shown poor or dangerous results.

Somewhat disturbing in the mid-May AP story was an estimate that about 1.2 million U.S. children are taking medications for type 2 diabetes, sleeping problems and stomach concerns – all of which were described as “adult conditions.”

At young ages, it’s probably not a good idea to expose children, or adults for that matter, to the risk of dependency on sleeping pills, as well as to the side effects of antacids and acid blockers.

Drugs that inhibit natural acid production are associated with increased risk of hip fractures, likely because calcium is not sufficiently absorbed, according to a story from MSNBC. In addition, restrained acid production could increase the risk of intestinal infection and bacterial overgrowth in the stomach and small intestine. According to MSNBC, the overgrowth of bacteria in the stomach could lead to pneumonia, vitamin B12 deficiency and stomach cancer.

Antacids, such as Tums and Rolaids, can cause problems with protein digestion and vitamin B12 absorption. Long-term use can interfere with absorption of other nutrients, including iron and calcium.

For safe, natural and nonaddictive support, WellZymes™ Sleep Enhance or any digestive enzyme supplement in the WellZymes™ line would make excellent alternatives to prescription drugs. Enzyme-based digestive supplements help address the root cause of stomach problems – improper digestion – rather than mask symptoms.

And as an alternative to blood pressure- and cholesterol-lowering drugs, WellZymes™ Cardiovascular Health provides herbs, nutrients and enzymes for maintaining healthy blood levels of cholesterol and triglycerides. From your health care practitioner, be sure to ask about BioSET™ Vascular Maintenance,™ which is indicated for high blood levels of cholesterol and/or triglycerides.

The Fibromyalgia Coalition International (FCI) will play host to its eighth annual Fibromyalgia and Chronic Fatigue Syndrome Awareness Conference on May 16-17 in Overland Park, Kan.

The metro Kansas City event will feature presentations from fibromyalgia/chronic fatigue syndrome experts who will provide insight into cutting-edge research and treatment protocols, according to FCI. A Health Care Providers workshop will take place May 16 from 8:30 a.m. to noon. Health care practitioners can receive continuing education for attending the entire conference.

Enzymes, Inc., is a sponsor of the conference along with Creative Wellness Center of Kansas City, Mo. Enzymes, Inc., will be located at booth 10, while Creative Wellness Center will be at booth 11.

There are several products in the WellZymes™ line of nutritional enzyme supplements that can help with symptoms of fibromyalgia. In particular, Enzymes, Inc., plans to provide attendees with samples of WellZymes™ Fibro Ease™ and WellZymes™ Gastric Ease.™

Fibro Ease™ has been formulated to relieve muscle tenderness and enhance nutrient delivery to muscle and nerve cells. Gastric Ease,™ which can be used in place of antacids, provides a complete blend of digestive enzymes along with soothing herbs to support proper digestion.

The conference will take place at the Marriott Hotel in Overland Park. For more information on FCI and the conference, visit the coalition Web site at www.fibrocoalition.org or call 913-384-4673. For room reservations, call the Marriott at 913-451-8000.

Fibromyalgia Awareness Day is May 12.